Applied DNA Cannabis Partner TheraCann International Secures Agreement with South Africa’s House of Hemp
10 June 2019 - 10:00PM
Business Wire
Includes Implementation of TheraCann’s ETCH
biotrace™ platform Utilizing Technology from Applied DNA
Applied DNA Sciences Inc. (NASDAQ:APDN) (“Applied DNA”), a
leader in PCR-based DNA manufacturing for product authenticity and
traceability solutions, announced that its strategic partner to the
global cannabis industry, TheraCann International Benchmark
Corporation (“TheraCann”), has secured a collaboration agreement
with House of Hemp (HoH), a licensed pioneer in South African
fiber, seed, oil and Cannabidiol (CBD) medicinal production. The
collaboration includes the implementation of TheraCann’s
molecular-tagging ETCH biotrace technology that uses a physical
molecular tag exclusively supplied by Applied DNA. TheraCann
was selected by HoH to be their technical expert and project
management team to achieve medical GMP standard for international
cannabis export and to provide the necessary technologies to track
every gram, every penny, and to ensure crop quality and
reliability.
Link to original TheraCann press release:
https://www.prnewswire.com/news-releases/theracann-and-house-of-hemp-enter-collaboration-agreement-to-build-a-sustainable-cannabis-industry-in-south-africa-300864076.html
John Shearman, VP for APDN’s Cannabis business, stated: “The
agreement with HOH demonstrates the pipeline of leads and
opportunities are converting into business agreements across an
array of various use case for the ETCH platform.”
About Applied DNA SciencesApplied DNA is a provider of
molecular technologies that enable supply chain security,
anti-counterfeiting and anti-theft technology, product genotyping
and pre-clinical nucleic acid-based therapeutic drug
candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking StatementsThe statements made by Applied
DNA in this press release may be “forward-looking” in nature within
the meaning of the Private Securities Litigation Act of 1995.
Forward-looking statements describe Applied DNA’s future plans,
projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to its history of
net losses, limited financial resources, limited market acceptance,
shifting enforcement priorities of US federal laws relating to
cannabis, and various other factors detailed from time to time in
Applied DNA’s SEC reports and filings, including our Annual Report
on Form 10-K filed on December 18, 2018 and our subsequent
quarterly report on Form 10-Q filed on May 9, 2019, and other
reports we file with the SEC, which are available at www.sec.gov.
Applied DNA undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190610005206/en/
investors: Sanjay M. Hurry, LHA Investor Relations,
212-838-3777, shurry@lhai.comprogram: John Sherman,
631-240-8838, john.shearman@adnas.comweb: www.adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024